Aberrant BNC1 silence induced by promoter hypermethylation has been reported in several types of human tumors, including pancreatic cancer, renal cell carcinoma, lung cancer, lymphocytic leukemia and the metastatic brain tumors [9,10,11,12,13]. This evidence concerns the gene BNC1 and hereditary clear cell renal cell carcinoma.